Molaz Molnupiravir 200 Mg Capsule

This medication is intended for early use, typically within 5 days of symptom onset, and is part of emergency or conditional approvals in several countries.

Key Benefits

• Oral treatment for COVID-19 – no injection required
• Reduces risk of hospitalization and severe disease
• Effective against various COVID-19 variants
• Short treatment course (5 days)
• Well-tolerated in most patients

Product Details

• Brand Name: Molaz
• Generic Name: Molnupiravir
• Strength: 200 mg per capsule
• Form: Oral capsule
• Pack Size: Typically 40 capsules (5-day treatment)
• Storage: Store below 30°C in a dry place

Dosage & Administration

• Recommended dose: 800 mg (4 capsules) every 12 hours for 5 days
• Take with or without food
• Complete the full 5-day course even if symptoms improve
• Do not take more than the prescribed dose

Safety & Precautions

• Not recommended during pregnancy or breastfeeding
• Use contraception during and after treatment (up to 4 days for women, 3 months for men)
• Consult a doctor before use if you have liver or kidney issues
• For use in adults only (18+ years)
• Keep out of reach of children

FAQs

1. What is Molaz (Molnupiravir) 200 mg used for?

It is used for the early treatment of mild to moderate COVID-19 in adults at high risk of progression to severe illness.

2. How quickly should I start taking it?

It should be started within 5 days of the onset of COVID-19 symptoms for best results.

3. Can I stop the medicine early if I feel better?

No, complete the full 5-day course even if symptoms improve to ensure effectiveness.

4. Is a prescription necessary?

Yes, Molnupiravir is a prescription-only medication and should be taken under medical supervision.

5. Can pregnant women take Molnupiravir?

No, it is not recommended for use during pregnancy due to potential risks to the fetus.